Pricing Log in Create free account

Bionano Genomics, Inc. (BNGO) vs Cuprina Holdings (Cayman) Limited (CUPR)

Bionano Genomics, Inc. and Cuprina Holdings (Cayman) Limited are both Medical Instruments & Supplies companies. Bionano Genomics, Inc. is the larger, with a market value of $16.1M against $11.5M — 1.4× the size. Across the 5 metrics below, Cuprina Holdings (Cayman) Limited leads on 3 and Bionano Genomics, Inc. on 2.

Valuation

Metric BNGO CUPR Medical Instruments & Supplies median
P/E n/m — 33.75
P/S 0.48 — 2.52
P/B 0.46 n/m 2.48
Price to free cash flow n/m — 25.19
EV/EBITDA n/m n/m 14.62
EV/Sales 0.72 n/m 2.88
Earnings yield (241.60%) — (2.67%)
Free cash flow yield (142.62%) — 0.09%

Profitability

Metric BNGO CUPR Medical Instruments & Supplies median
Gross margin 47.51% — 54.29%
Operating margin (106.67%) — 1.07%
Net margin (106.58%) — (1.61%)
Free cash flow margin (67.87%) — 1.08%
Return on equity (83.56%) — (1.32%)
Return on assets (52.04%) — 0.00%
Return on invested capital (81.68%) 0.00% 0.00%

Growth

Metric BNGO CUPR Medical Instruments & Supplies median
Revenue growth (TTM) 10.03% — 8.85%
EPS growth (last fiscal year) 94.50% (200.00%) 8.65%
Revenue growth, 5-year CAGR 27.37% — 9.17%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BNGO CUPR Medical Instruments & Supplies median
Debt to equity 0.11 0.07 0.10
Current ratio 2.48 2.35 2.48
Net debt to EBITDA 1.06 0.57 0.89

Dividend

Metric BNGO CUPR Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric BNGO CUPR Medical Instruments & Supplies median
Market cap 16.13m 11.48m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack